Nicole M Iovine, MD, PhD
Clinical Professor, Hospital Epidemiologist and Interim Chief of Hematology/Oncology
On This Page
About Nicole M Iovine
Accomplishments
-
Fellow of the Infectious Disease Society of America
Infectious Disease Society of America
-
Outstanding Leadership in Quality and Patient Safety
University of Florida Health
-
Excellence in Teaching Award
University of Florida
-
Special Citation of Excellence for a Poster Presentation
43rd Annual Meeting of the IDSA
-
Infectious Disease Fellow of the Year
New York University
-
Alpha Omega Alpha Honor Society
New York University School of Medicine
-
Golden Key National Honor Society
City University of New York
-
Valedictorian
City University of New York
Teaching Profile
Courses Taught
-
MDT7200 – Elect Top/Medicine
College of Medicine
-
BMS6300 – Fund Micro and Immuno
College of Medicine
Board Certifications
-
Infectious DiseaseAmerican Board of Internal Medicine
-
Internal MedicineAmerican Board of Internal Medicine
Clinical Profile
Specialties
- Infectious Disease
Areas of Interest
- Avian Influenza
- Coronavirus Disease 2019 (COVID-19)
- Infectious Diseases
Research Profile
I am trained as both an Infectious Disease specialist and as an expert in innate defense against bacterial infection, with a focus on Gram-negative organisms. As an Infectious Disease specialist, I am particularly interested in treatment approaches to multidrug-resistant Gram-negative infections. As a researcher, I study the innate defenses against these types of infections. In one project, I study the Bactericidal/Permeability-Increasing protein (BPI) – an endogenous antibiotic found in neutrophils and available in recombinant form. BPI has potent activity against Gram-negative bacteria, including multidrug-resistant clinical isolates I collect.
I have also studied emerging infections, such as chikungunya, Zika and seasonal influenza. I was engaged in two NIH-sponsored clinical trials for the treatment of seasonal influenza with immune plasma and triple therapy (ribivirin, oseltamivir and amantadine). I was the Principal Investigator for UF site of the NIH-sponsored Adaptive COVID-19 Treatment Trials (ACTT), which identified remdesivir and baricitinib as important agents for the treatment of COVID patients. Most recently, I am the Principal Investigator for the UF site of the STOMP monkeypox clinical trial, and for the Accelerating COVID-19 Therapeutic Interventions and Vaccines clinical trials (ACTIV4a and ACTIV4d).
0000-0002-5032-6485
Publications
Academic Articles
Grants
Education
-
Fellowship – Infectious Disease
New York University
-
Residency – Internal Medicine
New York University
-
Internship – Internal Medicine
New York University
-
Medical Degree
New York University
-
Doctor of Philosophy
New York University
-
Bachelor of Arts – Biology
City University of New York
Contact Details
- Business:
- (352) 273-8606
- Business:
- nicole.iovine@medicine.ufl.edu
- Business Mailing:
-
PO Box 100289
GAINESVILLE FL 32610 - Business Street:
-
1600 SW Archer Road, D2-39
GAINESVILLE FL 32611